ezlopitant has been researched along with nicotine in 1 studies
| Studies (ezlopitant) | Trials (ezlopitant) | Recent Studies (post-2010) (ezlopitant) | Studies (nicotine) | Trials (nicotine) | Recent Studies (post-2010) (nicotine) |
|---|---|---|---|---|---|
| 22 | 2 | 1 | 28,519 | 2,280 | 9,302 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eggan, BL; McCallum, SE | 1 |
1 other study(ies) available for ezlopitant and nicotine
| Article | Year |
|---|---|
α3β4 nicotinic receptors in the medial habenula and substance P transmission in the interpeduncular nucleus modulate nicotine sensitization.
Topics: Analysis of Variance; Animals; Benzylamines; Bridged Bicyclo Compounds, Heterocyclic; Cholinergic Antagonists; Chromatography, High Pressure Liquid; Dihydro-beta-Erythroidine; Dopamine; Dose-Response Relationship, Drug; Female; Interpeduncular Nucleus; Microdialysis; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Signal Transduction; Substance P | 2017 |